Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in H1 2017

European Healthtech startup funding raised during H1 2017.

In H1 2017, 215 European Healthtech companies closed 229 funding rounds and raised €1.8B in equity funding (excluding debt and grants), up 67.1% versus H1 2016. Debt rounds added €7.0M. Israel led by capital raised, and Bpifrance was the most active investor. Data as of 20 Nov 2026.

Equity funding
€1.8B
+67.1% vs H1 2016 · excl. debt & grants · +€7.0M debt
Funding rounds
229
+35.5% vs H1 2016
Companies
215
Top country
Israel
Rank among sectors
#3
8.8% of sector funding
Debt financing
€7.0M
0.4% of total
Top-10 round share
35.5%
of disclosed capital
Rounds ≥ €100M
1

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, H1 2017 — interactive chart.
Data table
FundingRounds
Jan€158M28
Feb€62M21
Mar€192M30
Apr€799M74
May€359M47
Jun€195M29

Top countries

by € raised
Healthtech — top countries by capital, H1 2017 — interactive chart.
Data table
Healthtech — top countries by capital, H1 2017
Israel€385M
UK€368M
Sweden€251M
France€226M
Switzerland€158M
Germany€153M
Spain€68M
Ireland€38M

Stage mix

by € raised
Healthtech — stage mix, H1 2017 — interactive chart.
Data table
Healthtech — stage mix, H1 2017
Other€861M
Series A€250M
Series D+€187M
Series B€167M
Series C€136M
Early VC€82M
Growth/Late€53M
Seed€21M
Debt€7.0M
Grant€1.8M

Exits & M&A

14 Acquisition · 1 IPO · 1 Merger

16 exits · €362M disclosed.

Zur RoseIPOJan 2017€184M
Europa ApotheekAcquisitionFeb 2017€126M
CrosponAcquisitionMay 2017€41M
Evoxx TechnologiesAcquisitionFeb 2017€7.7M
BiotechwareAcquisitionMay 2017€2.0M
Cipla CroatiaAcquisitionMay 2017€1.0M

Top deals

largest disclosed rounds in H1 2017
CompanyStageDateAmount
InsightecSeries D+Apr 2017€140M
BimaOtherApr 2017€91M
BiocartisOtherApr 2017€80M
BabylonOtherApr 2017€56M
Simba SleepSeries BApr 2017€47M
XeltisSeries CApr 2017€45M
Market LogicOtherMay 2017€45M
Breath TherapeuticsSeries AMar 2017€44M
Impulse DynamicsOtherMay 2017€41M
Vivet TherapeuticsSeries AMay 2017€38M
StarLeafOtherMay 2017€37M
DoctolibOtherApr 2017€35M
MedlumicsSeries BMar 2017€34M
ALung TechnologiesSeries CApr 2017€34M
Atlas GeneticsSeries D+Jan 2017€32M

Top investors

most active in H1 2017, by deal count